Loading
Alzheimer Disease / Clinically Designed Improvisatory Music · Interventional Study
ClinicalTrials.gov · August 10, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a clinical trial registration for an ongoing study of Clinically Designed Improvisatory Music (CDIM) in Alzheimer's disease patients with anxiety. No results are yet reported; the trial aims to measure anxiety and neuropsychiatric symptoms over 3 years in a small, non-randomized sample.
Interventional, Non Randomized, Parallel, Open label, Supportive Care purpose. Alzheimer Disease; age from 55 Years; to 100 Years; accepts healthy volunteers. Intervention: Alzheimer Disease (AD); Cognitively Healthy (CH). n = 30. 1 site: United States.
This is a clinical trial registration for an ongoing study of Clinically Designed Improvisatory Music (CDIM) in Alzheimer's disease patients with anxiety. No results are yet reported; the trial aims to measure anxiety and neuropsychiatric symptoms over 3 years in a small, non-randomized sample.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
No clinical impact can be assessed from a registry record without results. Clinicians should await outcome reporting before considering CDIM for anxiety in Alzheimer's disease.
This is a registry record for an ongoing interventional study with no results posted; enrollment and primary outcomes are planned but not yet measured.
As stated by the source record.
Quoted from the source exactly as published.
No clinical impact can be assessed from a registry record without results. Clinicians should await outcome reporting before considering CDIM for anxiety in Alzheimer's disease.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05477862). This is a study registration, not published results. Lead sponsor: Northwestern University. Recruitment status: ENROLLING_BY_INVITATION. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 30 participants (ESTIMATED). Conditions: Alzheimer Disease. Interventions: BEHAVIORAL: Clinically Designed Improvisatory Music. Primary outcome measures: Change in Neuropsychiatric Inventory (NPI) [NPI-1: pre-intervention; NPI-2: post-intervention] , Through study completion (3 years); Change in Beck Anxiety Inventory [BAI-1: pre-intervention; BAI-2: post-intervention] , Through study completion (3 years). Brief summary: Clinically Designed Improvisatory Music (CDIM) is a form of improvised music based on calm-inducing sound parameters which brought relief to our cohort of neurology patients. As a direct sound-based approach, CDIM does not rely on autobiographical memory and may have wider applicability and generalizability. We wish to examine if CDIM decreases anxiety in 15 cognitively healthy individuals and 15 Alzheimer Disease patients with anxiety (AD-A).
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.